LYNDA LOPEZ-FREYRE: Open Payments
NPI 1730425695 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 7 payments from 6 companies in 2025. Trend: 2023 $56 · 2024 $148 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $144 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $121 |
| Lilly USA, LLC | 1 | $112 |
| Noven Therapeutics, LLC | 2 | $39 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $15 |
Products named: REXULTI, FANAPT, CAPLYTA, KISUNLA, Xelstrym, Quviviq.
Industry payments across CA — which companies pay providers there.
